Source: MarketScreener

Hamatogenix: Hematogenix : Announces the Availability of COVID-19 Antibody Testing

(marketscreener.com) TINLEY PARK, Ill., June 10, 2020 /PRNewswire/ -- Hematogenix® announces the offering of COVID-19 antibody testing from blood samples using the Elecsys® Anti-SARS-CoV-2 test developed by Roche. The offering of this test, which the U.S. Food & Drug Administration has approved with emergency use authorization1, reaffirms Hematogenix's...https://www.marketscreener.com/news/Hematogenix-Announces-the-Availability-of-COVID-19-Antibody-Testing--30751168/?utm_medium=RSS&utm_content=20200610

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
100-250
Hytham Al-Masri's photo - CEO of Hamatogenix

CEO

Hytham Al-Masri

CEO Approval Rating

- -/100

Read more